Profil
Raegan McClain is currently the Chief Compliance Officer at Oyster Point Pharma, Inc. She has an undergraduate degree from The Pennsylvania State University and a graduate degree from the University of Pittsburgh Law School.
Postes actifs de Raegan McClain
| Sociétés | Poste | Début |
|---|---|---|
| OYSR POIN | Compliance Officer | 24/11/2021 |
Formation de Raegan McClain
| The Pennsylvania State University | Undergraduate Degree |
| University of Pittsburgh Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
